Diet-Induced Obesity Impairs Outcomes and Induces Multi-Factorial Deficiencies in Effector T Cell Responses Following Anti-CTLA-4 Combinatorial Immunotherapy in Renal Tumor-Bearing Mice
Associations between modifiable factors and the efficacy of cancer immunotherapies remain uncertain. We found previously that diet-induced obesity (DIO) reduces the efficacy of an immunotherapy consisting of adenovirus-encoded TRAIL plus CpG oligonucleotide (AdT/CpG) in mice with renal tumors. To el...
Main Authors: | William J. Turbitt, Shannon K. Boi, Justin T. Gibson, Rachael M. Orlandella, Lyse A. Norian |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/10/2295 |
Similar Items
-
The Antidiabetic Agent Acarbose Improves Anti-PD-1 and Rapamycin Efficacy in Preclinical Renal Cancer
by: Rachael M. Orlandella, et al.
Published: (2020-10-01) -
Obesity-Associated Myeloid-Derived Suppressor Cells Promote Apoptosis of Tumor-Infiltrating CD8 T Cells and Immunotherapy Resistance in Breast Cancer
by: Justin T. Gibson, et al.
Published: (2020-10-01) -
Re-Evaluating the Effects of Obesity on Cancer Immunotherapy Outcomes in Renal Cancer: What Do We Really Know?
by: Kristine I. Farag, et al.
Published: (2021-08-01) -
Rapid maturation of effector T cells in tumors, but not lymphoid organs, during tumor regression.
by: Lyse A Norian, et al.
Published: (2007-09-01) -
Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma
by: Janet Retseck, et al.
Published: (2018-07-01)